Update README.md
Browse files
README.md
CHANGED
|
@@ -1,3 +1,57 @@
|
|
| 1 |
-
---
|
| 2 |
-
license: cc-by-4.0
|
| 3 |
-
---
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
---
|
| 2 |
+
license: cc-by-4.0
|
| 3 |
+
---
|
| 4 |
+
|
| 5 |
+
# Human Interleukin-6 Nanobody Interaction Dataset (AVIDa-hIL6)
|
| 6 |
+
|
| 7 |
+
## Dataset Overview
|
| 8 |
+
|
| 9 |
+
AVIDa-hIL6 is an antigen-variable domain of heavy chain antibody (VHH) interaction dataset produced from an alpaca immunized with the human interleukin-6 (IL-6) protein. The dataset includes binary labels indicating the binding or non-binding of diverse VHH sequences to wild type and 30 mutants of the IL-6 protein.
|
| 10 |
+
|
| 11 |
+
This dataset enables the evaluation of computational models for predicting nanobody binding to different IL-6 protein variants, which is important for developing therapeutic antibodies against IL-6-related diseases and understanding antibody specificity.
|
| 12 |
+
|
| 13 |
+
## Data Collection
|
| 14 |
+
|
| 15 |
+
The data was collected from experiments with an alpaca immunized with human IL-6 protein. Binding assays were conducted to determine whether specific VHH sequences bind to wild-type IL-6 and its mutant variants. Further details are described in the paper "AVIDa-hIL6: A Large-Scale VHH Dataset Produced from an Immunized Alpaca for Predicting Antigen-Antibody Interactions."
|
| 16 |
+
|
| 17 |
+
## Dataset Structure
|
| 18 |
+
|
| 19 |
+
The dataset is strategically split into training, validation, and test sets to evaluate model generalization:
|
| 20 |
+
|
| 21 |
+
- **Training set**: Contains wild-type (WT) IL-6 protein data
|
| 22 |
+
- **Validation set**: Includes 5 randomly selected IL-6 mutants (randomly sampled 10% from the original validation set due to its large size)
|
| 23 |
+
- **Test set**: Comprises the remaining 25 IL-6 mutants for final performance evaluation
|
| 24 |
+
|
| 25 |
+
### File Format
|
| 26 |
+
|
| 27 |
+
#### Main Dataset File (AVIDa-hIL6.csv)
|
| 28 |
+
|
| 29 |
+
| Column | Description |
|
| 30 |
+
|--------|-------------|
|
| 31 |
+
| VHH_sequence | Amino acid sequence of VHH |
|
| 32 |
+
| Ag_label | Antigen Type |
|
| 33 |
+
| label | Binary label represented by 1 for binding pair and 0 for non-binding pair |
|
| 34 |
+
| subject_species | Species of the subject from which VHH was collected |
|
| 35 |
+
| subject_name | Name of the subject from which VHH was collected |
|
| 36 |
+
| subject_sex | Sex of the subject from which VHH was collected |
|
| 37 |
+
|
| 38 |
+
#### Antigen embedding File (antigen_embeddings.pt)
|
| 39 |
+
precomputed antigen sequence embeddings through ESM-2 (650M)
|
| 40 |
+
|
| 41 |
+
## Uses and Limitations
|
| 42 |
+
|
| 43 |
+
### Uses
|
| 44 |
+
- Develop models to predict nanobody binding to IL-6 and its variants
|
| 45 |
+
- Identify nanobodies with specific or broad recognition of IL-6 mutants
|
| 46 |
+
- Understand the impact of IL-6 mutations on antibody recognition
|
| 47 |
+
- Design therapeutic nanobodies for inflammatory and autoimmune diseases
|
| 48 |
+
|
| 49 |
+
## Evaluation Metrics
|
| 50 |
+
|
| 51 |
+
Model performance is evaluated using:
|
| 52 |
+
- Accuracy
|
| 53 |
+
- F1 Score
|
| 54 |
+
- Precision
|
| 55 |
+
- Recall
|
| 56 |
+
- AUROC (Area Under the Receiver Operating Characteristic curve)
|
| 57 |
+
- AUPRC (Area Under the Precision-Recall Curve)
|